Yumanity Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $18.67 Millions, with shareholders equity totaling $5.48 Millions.
The company employs approximately 46 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Yumanity Therapeutics Inc. reported $1.10 Million in revenue, generating net income of $-32.00 Millions.
Key financial metrics include a P/E ratio of -0.58, a price-to-book (P/B) ratio of 3.41, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker YMTX.